HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of cytokeratin and erbB-2 oncoprotein in Paget's disease of the nipple. An immunohistochemical study.

Abstract
The occurrence of epithelial membrane antigen (EMA), low molecular weight cytokeratin (CK) and erbB-2 oncoprotein was investigated in twenty-eight cases of Paget's disease of the nipple (PD) to determine their diagnostic usefulness. The ABC technique with monoclonal antibodies was used on formalin-fixed, paraffin-embedded tissue. The Paget's cells showed positive immunoreactivity for all three antigens investigated in a high percentage of PD. Immunoreactivity for CK and erbB-2 oncoprotein was restricted to the Paget's cells, whereas EMA in some cases also stained the adjacent keratinocytes. Since CK and/or erbB-2 oncoprotein occurred in 93% of the cases, we conclude that demonstration of both antigens is useful in the diagnosis of PD. ErbB-2 oncoprotein was also found to be expressed in a high percentage of the underlying intraductal and invasive carcinomas.
AuthorsT Haerslev, G Krag Jacobsen
JournalAPMIS : acta pathologica, microbiologica, et immunologica Scandinavica (APMIS) Vol. 100 Issue 11 Pg. 1041-7 (Nov 1992) ISSN: 0903-4641 [Print] Denmark
PMID1282021 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Membrane Glycoproteins
  • Mucin-1
  • Proto-Oncogene Proteins
  • Keratins
  • Receptor, ErbB-2
Topics
  • Carcinoma, Intraductal, Noninfiltrating (pathology)
  • Humans
  • Immunoenzyme Techniques
  • Keratins (metabolism)
  • Membrane Glycoproteins (metabolism)
  • Mucin-1
  • Nipples (metabolism)
  • Paget's Disease, Mammary (metabolism)
  • Proto-Oncogene Proteins (metabolism)
  • Receptor, ErbB-2

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: